Diadia
Our TechnologyResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

metabolic · Mechanism Report

Can MTR rs1805087 and MTHFD1 rs2236225 reduce one-carbon pathway flexibility?

These variants can reduce one-carbon pathway flexibility, which may limit remethylation capacity and raise homocysteine, with subtle effects on red blood cell maturation.

PlausibleJuly 17, 202616 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

MTR rs1805087 and MTHFD1 rs2236225 variants can reduce one-carbon pathway flexibility, limiting remethylation capacity and contributing to elevated homocysteine and subtle red blood cell maturation changes.

laying out figure…
2 of 6 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

The claim says the MTR rs1805087 and MTHFD1 rs2236225 variants can restrict folate-pathway flexibility. The mechanism frames this as reduced remethylation capacity, which is linked to elevated homocysteine. It also suggests a plausible downstream effect on erythroid DNA synthesis, producing subtle red blood cell maturation changes.

Verified conclusion

Genetic variations in key folate-pathway enzymes can significantly restrict metabolic flexibility, impacting downstream physiological markers like homocysteine and red blood cell dynamics.

Metabolic flexibility and homocysteine regulation

  • Enzymatic dysfunction: The MTR rs1805087 (A2756G) variant results in a D919G substitution that weakens S-adenosylmethionine (SAM) binding, directly reducing methionine synthase activity. Meanwhile, the MTHFD1 rs2236225 (1958G>A) variant causes an R653Q substitution that compromises cytoplasmic enzyme stability.
  • Remethylation impairment: These combined defects restrict the pathway's capacity to remethylate homocysteine back to methionine. This limitation directly contributes to cellular accumulation and elevated plasma homocysteine levels, particularly under nutrient-depleted or folate-restricted conditions.

Erythroid progenitor maturation mechanisms

  • Nucleotide synthesis limitation: Reduced one-carbon pathway flexibility compromises the synthesis of formyl and methylene tetrahydrofolate (THF) species, directly impairing thymidylate and purine synthesis.
  • Altered maturation: Insufficient nucleotide availability halts or slows DNA replication within rapidly proliferating erythroid progenitors. This induces subclinical blocks in DNA synthesis and delayed precursor maturation, potentially causing subtle macrocytic cellular shifts.
  • Clinical status: Although these mechanisms are biochemically clear, direct clinical associations with markers like mean corpuscular volume (MCV) or red cell distribution width (RDW) are modest, highly polygenic, and largely dependent on environmental stressors like borderline folate or B12 deficiency.

Bottom line

  • The MTR rs1805087 and MTHFD1 rs2236225 variants limit one-carbon pathway flexibility and remethylation capacity, directly contributing to elevated homocysteine and plausibly inducing subtle red blood cell maturation changes by restricting DNA synthesis in erythroid precursors.

References

  1. Association of MTR gene polymorphisms with the ... — nature.com ↗
  2. [PDF] RELATIONSHIP OF POLYMORPHISMS OF MTR GENE rs1805087 ... — repository.tma.uz ↗
  3. Methionine synthase A2756G polymorphism influences ... — pmc.ncbi.nlm.nih.gov ↗
  4. Association of thrombophilic genes (MTHFR, MTR and MTRR ... — sciencedirect.com ↗
  5. MTHFR C677T and MTR A2756G polymorphisms and ... - PMC — pmc.ncbi.nlm.nih.gov ↗
  6. Genetic variants in phosphatidylethanolamine N-methyltransferase (PEMT) and methylenetetrahydrofolate dehydrogenase (MTHFD1) influence biomarkers of choline metabolism when folate intake is restricted — linkinghub.elsevier.com ↗
  7. Evaluation of a methylenetetrahydrofolate-dehydrogenase ... — nature.com ↗
  8. Association of MTHFD1 G1958A (rs2236225) gene polymorphism ... — pmc.ncbi.nlm.nih.gov ↗
  9. MTHFD1: Folate and Choline — geneticlifehacks.com ↗
  10. Association of methionine synthase rs1801394 and ... — pmc.ncbi.nlm.nih.gov ↗
  11. MTHFD1 protein (human) — string-db.org ↗
  12. Genetic polymorphisms and folate status - PMC - NIH — pmc.ncbi.nlm.nih.gov ↗
  13. Polymorphisms in MTHFD1 Gene and Susceptibility to Neural Tube Defects: A Case-Control Study in a Chinese Han Population with Relatively Low Folate Levels - PubMed — pubmed.ncbi.nlm.nih.gov ↗
  14. MTR A2756G (rs1805087) - GeneOps — geneops.ai ↗
  15. Methylenetetrahydrofolate dehydrogenase (MTHFD) ... — pdfs.semanticscholar.org ↗
  16. MTHFR (C677T, A1298C) and MTRR (A66G) ... — pdfs.semanticscholar.org ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible8 sourcesDoes the MTHFR rs1801131 A1298C variant mildly reduce enzyme activity and have a smaller homocysteine effect than C677T?→Plausible3 sourcesIs TMAO formed from gut microbial conversion of choline and carnitine followed by liver oxidation?→